Market Trends Novo Nordisk reports interim results from late-stage trial of its haemophilia A treatmentBy admin8996erT0allFebruary 7, 2025 ismagilov Novo Nordisk announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with…
